# EDGAR Filing Document

**Accession Number:** 0002132871
**File Stem:** 0001122976-26-000101
**Filing Date:** 2026-6
**Character Count:** 12067
**Document Hash:** b5633c8730372beabf0995d2e040e2f9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001122976-26-000101.hdr.sgml**: 20260601

**ACCESSION NUMBER**: 0001122976-26-000101

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260601

**FILED AS OF DATE**: 20260601

**DATE AS OF CHANGE**: 20260601

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Di Salvo Giuseppe
- **CENTRAL INDEX KEY:** 0002132871

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16091
- **FILM NUMBER:** 261051973

**MAIL ADDRESS:**
- **STREET 1:** 33587 WALKER ROAD
- **CITY:** AVON LAKE
- **STATE:** OH
- **ZIP:** 44012
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AVIENT CORP
- **CENTRAL INDEX KEY:** 0001122976
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 341730488
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 33587 WALKER ROAD
- **CITY:** AVON LAKE
- **STATE:** OH
- **ZIP:** 44012
- **BUSINESS PHONE:** 440-930-1000

**MAIL ADDRESS:**
- **STREET 1:** 33587 WALKER ROAD
- **CITY:** AVON LAKE
- **STATE:** OH
- **ZIP:** 44012

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POLYONE CORP
- **DATE OF NAME CHANGE:** 20000830

## Ex-24

```

Know all by these presents that the undersigned hereby constitutes and appoints
each of Amy M. Sanders, Kristen A. Gajewski, Robert K. James, Ari M. Friedman,
Samuel V. Huryn, and Anne M. Stetz, signing singly, the undersigned's true and
lawful attorney-in-fact to: 1.	Prepare, execute in the undersigned's name and
on the undersigned's behalf, and submit to the U.S. Securities and Exchange
Commission (the "SEC") all forms and schedules, including Form ID, necessary to
complete the timely enrollment of the undersigned in the SEC's Electronic Data
Gathering, Analysis, and Retrieval ("EDGAR Next") system, and any and all
amendments thereto; and 2.	Do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to complete the execution
of any such form or schedule and the timely filing of such form or schedule
with the SEC; and 3.	Do and perform any and all acts required as an account
administrator of the undersigned's EDGAR Next account including, but not
limited to, managing the undersigned's EDGAR Next account, as well as
performing yearly acknowledgements and token management; and 4.	Execute for and
on behalf of the undersigned, in the undersigned's capacity as an officer
and/or director of Avient Corporation (the "Corporation"), Forms 3, 4, and 5 in
accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder; and 5.	Do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to complete and execute any
such Form 3, 4, or 5 and timely file such form with the SEC and any stock
exchange or similar authority; and 6.	Take any other action of any type
whatsoever in connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest of, or legally
required by, the undersigned, it being understood that the documents executed
by such attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and conditions as
such attorney-in-fact may approve in such attorney-in-fact's discretion. The
undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Corporation assuming, any of the undersigned's responsibility to
comply with Section 16 of the Securities Exchange Act of 1934. This Power of
Attorney shall remain in full force and effect until the undersigned is no
longer required to file Forms 3, 4, and 5 with respect to the undersigned's
holdings of and transactions in securities issued by the Corporation, unless
earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused
this Power of Attorney to be executed as of this 29th day of April, 2026. /s/
Giuseppe Di Salvo

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Di Salvo Giuseppe<br><sub>(Last) (First) (Middle)</sub><br>AVIENT CORPORATION<br>33587 WALKER ROAD<br><sub>(Street)</sub><br>AVON LAKE, OH 44012<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>AVIENT CORP [ AVNT ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-06-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_SVP, Chief Financial Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 18300.401 | I | Supplemental Plan<sup>(1)</sup> |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 1761 | <sup>(3)</sup> | D |  |
| Restricted Stock Units | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 1179 | <sup>(3)</sup> | D |  |
| Restricted Stock Units | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 2783 | <sup>(3)</sup> | D |  |
| Stock Appreciation Rights | <sup>(6)</sup> | 2029-02-11 | Common Stock | 1637 | $31.54 | D |  |
| Stock Appreciation Rights | <sup>(7)</sup> | 2030-02-10 | Common Stock | 3713 | $31.48 | D |  |
| Stock Appreciation Rights | <sup>(8)</sup> | 2031-02-08 | Common Stock | 5470 | $42.27 | D |  |
| Stock Appreciation Rights | <sup>(9)</sup> | 2032-02-14 | Common Stock | 4250 | $52.64 | D |  |
| Stock Appreciation Rights | <sup>(10)</sup> | 2033-02-17 | Common Stock | 5000 | $42.93 | D |  |
| Stock Appreciation Rights | <sup>(11)</sup> | 2034-02-22 | Common Stock | 5250 | $39.27 | D |  |

---

### Footnotes:

(1) The information in this report is based on a plan statement as of June 1, 2026.

(2) The restricted stock units vest 3 years from the date of grant on February 22, 2027.

(3) Each restricted stock unit represents a contingent right to receive one share of Avient common stock.

(4) The restricted stock units vest in substantially equal installments on each of February 19, 2027 and February 19, 2028, unless earlier vested or terminated pursuant to the terms of the grant agreement.

(5) The restricted stock units vest in substantially equal installments on each of February 20, 2027, February 20, 2028 and February 20, 2029, unless earlier vested or terminated pursuant to the terms of the grant agreement.

(6) Stock appreciation rights ("SARs") become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.

(7) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.

(8) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $42.27 per share and no more than one-third of the grant can vest per year during the first three years

(9) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.

(10) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $42.93 per share and no more than one-third of the grant can vest per year during the first three years.

(11) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $39.27 per share and no more than one-third of the grant can vest per year during the first three years.

**Remarks:**
Exhibit 24.1 - Power of Attorney

**Signature:** /s/ Robert K. James, Power of Attorney for Giuseppe Di Salvo  
**Date:** 2026-06-01

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**